LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 2 of 520
Next
>>
>
26 to 50 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	AZD7762	0.04	uM	LJP6	2	L06	72	hr	1334	4174	3899	1.0705	1.0901
BT-20	AZD7762	0.12	uM	LJP6	2	L05	72	hr	1334	3474	3899	0.8910	0.8562
BT-20	AZD7762	0.12	uM	LJP6	3	L05	72	hr	1334	3598	3921	0.9175	0.8923
BT-20	AZD7762	0.37	uM	LJP6	2	L04	72	hr	1334	3082	3899	0.7904	0.7179
BT-20	AZD7762	0.37	uM	LJP6	3	L04	72	hr	1334	3027	3921	0.7719	0.6933
BT-20	Seliciclib	0.04	uM	LJP5	1	J06	72	hr	1334	4134	3930	1.0517	1.0658
BT-20	Seliciclib	0.04	uM	LJP5	2	J06	72	hr	1334	4081	4051	1.0074	1.0092
BT-20	Seliciclib	0.12	uM	LJP5	1	J05	72	hr	1334	3991	3930	1.0153	1.0196
BT-20	Seliciclib	0.12	uM	LJP5	2	J05	72	hr	1334	4160	4051	1.0269	1.0334
BT-20	Seliciclib	0.37	uM	LJP5	2	J04	72	hr	1334	3836	4051	0.9469	0.9330
BT-20	Seliciclib	0.37	uM	LJP5	3	J04	72	hr	1334	3792	4117	0.9209	0.9012
BT-20	Seliciclib	1.11	uM	LJP5	2	J03	72	hr	1334	3942	4051	0.9731	0.9662
BT-20	Seliciclib	1.11	uM	LJP5	3	J03	72	hr	1334	3837	4117	0.9318	0.9150
BT-20	Seliciclib	10	uM	LJP5	1	J01	72	hr	1334	1648	3930	0.4193	0.1449
BT-20	Seliciclib	10	uM	LJP5	2	J01	72	hr	1334	1837	4051	0.4535	0.2207
BT-20	AT-7519	0.04	uM	LJP6	1	K06	72	hr	1334	3808	3955	0.9626	0.9520
BT-20	AT-7519	0.04	uM	LJP6	2	K06	72	hr	1334	3887	3899	0.9969	0.9960
BT-20	AT-7519	0.12	uM	LJP6	2	K05	72	hr	1334	4021	3899	1.0313	1.0402
BT-20	AT-7519	0.12	uM	LJP6	3	K05	72	hr	1334	3647	3921	0.9300	0.9088
BT-20	AT-7519	0.37	uM	LJP6	2	K04	72	hr	1334	2962	3899	0.7597	0.6743
BT-20	AT-7519	0.37	uM	LJP6	3	K04	72	hr	1334	3094	3921	0.7890	0.7173
BT-20	AT-7519	3.33	uM	LJP6	2	K02	72	hr	1334	388	3899	0.0995	-0.5501
BT-20	AT-7519	3.33	uM	LJP6	3	K02	72	hr	1334	410	3921	0.1046	-0.5319
BT-20	AZD7762	3.33	uM	LJP6	2	L02	72	hr	1334	1361	3899	0.3491	0.0127
BT-20	AZD7762	3.33	uM	LJP6	1	L02	72	hr	1334	1448	3955	0.3661	0.0534

|<
<<
Previous
Page 2 of 520
Next
>>
>
26 to 50 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)